{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:40:09Z","timestamp":1789501209522,"version":"build-2803163510"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1017716"],"award-info":[{"award-number":["OPP1017716"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1062806"],"award-info":[{"award-number":["OPP1062806"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1115799"],"award-info":[{"award-number":["OPP1115799"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["R34 MH096606"],"award-info":[{"award-number":["R34 MH096606"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220345","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T13:28:53Z","timestamp":1564147733000},"page":"e0220345","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance"],"prefix":"10.1371","volume":"14","author":[{"given":"Joseph B.","family":"Sempa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-352X","authenticated-orcid":true,"given":"Shelley N.","family":"Facente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila M.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Pilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-7245","authenticated-orcid":true,"given":"Eduard","family":"Grebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"e44377","DOI":"10.1371\/journal.pone.0044377","article-title":"A General HIV Incidence Inference Scheme Based on Likelihood of Individual Level Data and a Population Renewal Equation","volume":"7","author":"GS Mahiane","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oxfordjournals.aje.a117404","article-title":"Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests","volume":"141","author":"R Brookmeyer","year":"1995","journal-title":"American journal of epidemiology"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.2006.22.945","article-title":"Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay","volume":"22","author":"JS McDougal","year":"2006","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007368","article-title":"A Comparison of Biomarker Based Incidence Estimators","volume":"4","author":"TA McWalter","year":"2009","journal-title":"PloS one"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1097\/QAD.0b013e32833f1142","article-title":"Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation","volume":"24","author":"MP Busch","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S0950268816002910","article-title":"Moving towards a reliable HIV incidence test\u2014current status, resources available, future directions and challenges ahead","volume":"145","author":"G Murphy","year":"2017","journal-title":"Epidemiology and Infection"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033328","article-title":"Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies","volume":"7","author":"YT Duong","year":"2012","journal-title":"PLOS ONE"},{"key":"ref8","unstructured":"Ministry of Health, Malawi. Malawi Population-Based HIV Impact Assessment (MPHIA) 2015-2016: Final Report; 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2018\/10\/MPHIA-Final-Report__10.25.18.pdf\" xlink:type=\"simple\">https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2018\/10\/MPHIA-Final-Report__10.25.18.pdf<\/ext-link>."},{"key":"ref9","unstructured":"Ministry of Health, Zambia. Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016: Final Report; 2019. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2019\/03\/ZAMPHIA-Final-Report__2.26.19.pdf\" xlink:type=\"simple\">https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2019\/03\/ZAMPHIA-Final-Report__2.26.19.pdf<\/ext-link>."},{"key":"ref10","unstructured":"HSRC. The Fifth South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017 (SABSSM V); 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hsrc.ac.za\/uploads\/pageContent\/9234\/SABSSMV_Impact_Assessment_Summary_ZA_ADS_cleared_PDFA4.pdf\" xlink:type=\"simple\">http:\/\/www.hsrc.ac.za\/uploads\/pageContent\/9234\/SABSSMV_Impact_Assessment_Summary_ZA_ADS_cleared_PDFA4.pdf<\/ext-link>."},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"e0161183","DOI":"10.1371\/journal.pone.0161183","article-title":"Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence","volume":"11","author":"Z Gao","year":"2016","journal-title":"PLOS ONE"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/aid.2013.0113","article-title":"Short Communication: Defining Optimality of a Test for Recent Infection for HIV Incidence Surveillance","volume":"30","author":"R Kassanjee","year":"2014","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0114947","article-title":"Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes","volume":"10","author":"YT Duong","year":"2015","journal-title":"PLOS ONE"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/aid.2016.0245","article-title":"Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence","volume":"33","author":"KE Schlusser","year":"2017","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/QAD.0000000000000429","article-title":"Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository","volume":"28","author":"R Kassanjee","year":"2014","journal-title":"AIDS"},{"issue":"15","key":"ref16","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0000000000001209","article-title":"Viral load criteria and threshold optimization to improve HIV incidence assay characteristics","volume":"30","author":"R Kassanjee","year":"2016","journal-title":"AIDS"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAI.0000000000001537","article-title":"Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms","volume":"76","author":"E Grebe","year":"2017","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Grebe E, Facente SN, Bingham J, Pilcher CD, Powrie A, Gerber J, et al. Interpreting Diagnostic Histories into HIV Infection Time Estimates: Framework and Online Tool. bioRxiv. 2018.","DOI":"10.1101\/323808"},{"key":"ref19","unstructured":"Maxim Biomedical. Maxim HIV-1 Limiting Antigen Avidity EIA: Single Well Avidity Enzyme Immunoassay for Detection of Recent HIV-1 Infection, Cat. No. 92001; 2013. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.maximbio.com\/img\/insert\/920013-Product-Insert.pdf\" xlink:type=\"simple\">http:\/\/www.maximbio.com\/img\/insert\/920013-Product-Insert.pdf<\/ext-link>."},{"key":"ref20","unstructured":"Sedia Biosciences Corporation. Sedia\u2122 HIV-1 LAg-Avidity EIA: single well avidity enzyme immunoassay for detection of recent HIV-1 infection, Cat. No. 1002; 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sediabio.com\/LiteratureRetrieve.aspx?ID=134692\" xlink:type=\"simple\">http:\/\/www.sediabio.com\/LiteratureRetrieve.aspx?ID=134692<\/ext-link>."},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/EDE.0b013e3182576c07","article-title":"A new general biomarker-based incidence estimator","volume":"23","author":"R Kassanjee","year":"2012","journal-title":"Epidemiology"},{"key":"ref22","unstructured":"Grebe E, B\u00e4umler P, McIntosh A, Ongarello S, Welte A. Incidence Estimation Tools (inctools); 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.5281\/zenodo.1493401\" xlink:type=\"simple\">https:\/\/doi.org\/10.5281\/zenodo.1493401<\/ext-link>."},{"key":"ref23","unstructured":"Grebe E. Incidence (combined method): PLOS ONE Publication; 2018. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.5281\/zenodo.1420559\" xlink:type=\"simple\">https:\/\/doi.org\/10.5281\/zenodo.1420559<\/ext-link>."},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0203638","article-title":"Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa","volume":"13","author":"E Grebe","year":"2018","journal-title":"PLOS ONE"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0172283","article-title":"Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma","volume":"12","author":"KE Schlusser","year":"2017","journal-title":"PLOS ONE"},{"key":"ref26","unstructured":"WHO. HIV drug resistance report 2017. World Health Organization; 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-report-2017\/en\/\" xlink:type=\"simple\">https:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-report-2017\/en\/<\/ext-link>."},{"key":"ref27","unstructured":"Duke Human Vaccine Institute. EQAPOL Limiting Antigen (LAg) Avidity Incidence Assay EQA Program; 2019. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/eqapol.dhvi.duke.edu\/programs\/lag\" xlink:type=\"simple\">https:\/\/eqapol.dhvi.duke.edu\/programs\/lag<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:52:00Z","timestamp":1588996320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220345"}},"subtitle":[],"editor":[{"given":"Remco PH","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220345","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/572677","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]}}}